When stratified analysis was conducted about different stages of NSCLC, the associations were also found in stages I to III, but not I-IV, with relatively larger sample pooled indicating that late-stage NSCLC patient confounded the observation of p16 methylation on survival. Here, CDKN2A is linked to non-small cell lung carcinoma.